|Salary:||£32,817 to £40,322|
|Placed On:||7th October 2021|
|Closes:||4th November 2021|
Faculty of Science
Term: Fixed (until 29/03/2025)
CMAC is a world leading medicines manufacturing research centre that hosts a portfolio of collaborative research programmes aimed to transform the development and manufacture of medicines (www.cmac.ac.uk). Building on our long standing partnerships with a wide range of pharmaceutical manufacturers, technology providers and leading universities, we are establishing a new EPSRC-funded Centre focussed on enabling digital transformation. The Made Smarter Innovation – Digital Medicines Manufacturing Research Centre (DM2) is a 3.5-year programme that will accelerate the adoption of industrial digital technologies (IDTs) in the pharma sector across five core Platforms covering data, advanced manufacturing, digital QC, patient centric supply and networking and skills. The DM2 Centre connects a leading multidisciplinary team of researchers across Strathclyde, Loughborough and Cambridge universities with leading digital technology providers, medicines manufacturers and healthcare providers, to drive a digital transformation in medicines manufacturing.
The five integrated Platforms designed by the academic and industrial researcher partners are: (1) The Data Platform; (2) Autonomous MicroScale Manufacturing Platform; (3) Digital Quality Control Platform; (4) Adaptive Digital Supply Platform; and (5) The DM2 Network & Skills Platform.
This ambitious programme is supported by a large team of Post-doctoral Research Associates, Research Technicians and management staff to plan, deliver and disseminate the ambitious research, networking and training activities.
We are currently seeking applicants for a PDRA post based at the University of Strathclyde within Platform 2 - Autonomous MicroScale Manufacturing. This Platform will accelerate development of medicine products and manufacturing processes by creating agile, small-scale production facilities that rapidly generate large data sets and drive research. Robotic technologies will be assembled to create a unique small-scale medicine manufacturing and testing system to select drug formulations and processes and produce stable products with the desired performance. Integrating several IDTs will accelerate drug product manufacture, significantly reducing experiments and dramatically reducing development time, raw materials and associated costs.
This is a unique opportunity to help realising the next generation of pharmaceutical production facilities through the development of a self-optimising medicine manufacturing platform capable of delivering microscale batches. You will work closely with the DM2 team and leading digital and pharmaceutical technology providers and global pharmaceutical companies.
You will have a PhD in a relevant subject (Chemical Engineering, Pharmaceutical Sciences, Mechanical Engineering, Chemistry, Physics, Computer Science or related discipline) with appropriate experience in modelling, simulation and optimisation ideally in a materials and/or processing area to implement the process/formulation optimisers and autonomously parameterise process and product models.
You must have excellent verbal and written communications skills with the ability to write clearly and succinctly for publication. You must also be able to work as a member of a research team, as well as demonstrate a successful track record of research achievement. You should be able to independently develop new concepts in your research, have excellent organisational skills, initiative, and the ability to pay close attention to detail.
Informal enquiries about the post can be directed to Dr Daniel Markl, DM2 Co-I and Platform 2 Lead. (firstname.lastname@example.org).
Type / Role: